Horizon Pharma to Present at the 12th Annual BIO Investor Forum

Horizon Pharma to Present at the 12th Annual BIO Investor Forum 
DEERFIELD, IL -- (Marketwired) -- 10/02/13 --  Horizon Pharma, Inc.
(NASDAQ: HZNP) today announced that Todd Smith, executive vice
president and chief commercial officer, will present at the 12th
Annual BIO Investor Forum on Wednesday, October 9, 2013 at 10:00 a.m.
Pacific Time (1:00 p.m. Eastern Time) in San Francisco, CA. Mr. Smith
will provide an overview of the Company and its corporate activities. 
The presentation will be webcast live and may be accessed by visiting
Horizon's website at 
 http://ir.horizon-pharma.com.  
About Horizon Pharma
 Horizon Pharma, Inc. is a specialty
pharmaceutical company that has developed and is commercializing
DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic
needs in arthritis, pain and inflammatory diseases. The Company's
strategy is to develop, acquire, in-license and/or co-promote
additional innovative medicines where it can execute a targeted
commercial approach in specific therapeutic areas while taking
advantage of its commercial strengths and the infrastructure the
Company has put in place. For more information, please visit
www.horizonpharma.com. 
Contacts
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
investor-relations@horizonpharma.com 
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
kgalante@burnsmc.com 
 
 
Press spacebar to pause and continue. Press esc to stop.